Diabetes and excessive weight are independent risk factors for adult asthma that have the potential to be modified.

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

There are sex-specific differences for risk factors, hospitalization rates, and in-hospital mortality in patients with stroke.

Patients aged 10 to 17 years who are prescribed GLP-1 RAs are more likely to have comorbid type 2 diabetes and more.

Facial volume loss and increased skin laxity were significant in the mid-cheek region after major weight loss, resulting in accelerated facial aging.

Patients with T2D with more severe peripheral neuropathy have a 4-fold DED risk compared with patients with mild or no peripheral neuropathy.